Application no. and date | 03770134.9 (espacenet) (Federated) (European Patent Register), 20031104 | Patent/reg. no. and date | DK/EP 1559427, 20110309 | Publication date | 20050803 | Priority no. and date | JP 2002323792, 20021107 | EP pub. no. and date |
EP 1559427 20050803 | Effective date | | Applicant/owner | Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-ku Tokyo 103-8411, JP | Applicant ref. no. | P48356dk01 | Inventor | SATO, Shuichi, Yamanouchi Pharm. Co., Ltd.,
21, Miyukigaoka
Tsukuba-shi,
Ibaraki 305-8585, JP, UKAI, Masashi, Yamanouchi Pharm. Co., Ltd.,
21, Miyukigaoka
Tsukuba-shi,
Ibaraki 305-8585, JP, MARUYAMA, Tatsuya, Yamanouchi Pharm. Co., Ltd.,
21, Miyukigaoka
Tsukuba-shi,
Ibaraki 305-8585, JP, TAKASU, Toshiyuki, Yamanouchi Pharm.Co., Inc.,
21, Miyukigaoka
Tsukuba-shi,
Ibaraki 305-8585, JP | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/426 (2006.01) , A61P 13/00 (2006.01) , A61P 13/10 (2006.01) , C07D 277/40 (2006.01) | Title | Lægemiddel til overaktiv blære omfattende eddikesyreanilidderivat som den aktive bestanddel | Int. application no. | JP2003014065 | Int. publication no. | WO2004041276 | Related patent (certificate) | CA 2013 00028 | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|